Pharma & Biotech

Pfizer is demonstrating tangible progress in its strategic shift away from reliance on COVID-19 products. A combination of promising clinical...

Shares of Sana Biotechnology opened the week with notable strength, buoyed by a significant price target revision from a major...

Investors demonstrated notable composure as news broke of a significant patent lawsuit against BioNTech. The German biotech firm, alongside its...

Medical device giant Baxter International is implementing a comprehensive financial and operational strategy to counter persistent margin compression and manufacturing...

Investors are piling into Ocugen, Inc., driving a significant rally in the biotech firm's share price. The upward momentum is...

BioNTech finds itself navigating a dual narrative this week, marked by a significant corporate milestone and the emergence of fresh...

Investors in Mainz-based biotechnology firm BioNTech are navigating a complex landscape of strategic progress and fresh legal uncertainty. The company...

A definitive chapter has closed for investors in CureVac. The German biotech firm's standalone history as a publicly traded company...

The start of 2026 presents a period of significant pressure for online pharmacy operator Redcare Pharmacy. The company's shares have...

Pharmaceutical giant Pfizer has framed 2026 as a definitive transitional period. The company's latest financial projections for revenue and earnings...